ATE279941T1 - Nicht-virulente porphyromonas gingivalis mutante - Google Patents

Nicht-virulente porphyromonas gingivalis mutante

Info

Publication number
ATE279941T1
ATE279941T1 AT99943674T AT99943674T ATE279941T1 AT E279941 T1 ATE279941 T1 AT E279941T1 AT 99943674 T AT99943674 T AT 99943674T AT 99943674 T AT99943674 T AT 99943674T AT E279941 T1 ATE279941 T1 AT E279941T1
Authority
AT
Austria
Prior art keywords
porphyromonas gingivalis
virulent
mammal
mutant
administering
Prior art date
Application number
AT99943674T
Other languages
English (en)
Inventor
Hansel M Fletcher
Original Assignee
Univ Loma Linda
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Loma Linda filed Critical Univ Loma Linda
Application granted granted Critical
Publication of ATE279941T1 publication Critical patent/ATE279941T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0216—Bacteriodetes, e.g. Bacteroides, Ornithobacter, Porphyromonas
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT99943674T 1998-08-12 1999-08-11 Nicht-virulente porphyromonas gingivalis mutante ATE279941T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/133,089 US6254863B1 (en) 1998-08-12 1998-08-12 Non-virulent Porphyromonas gingivalis mutant
PCT/US1999/018197 WO2000009156A1 (en) 1998-08-12 1999-08-11 Non-virulent porphyromonas gingivalis mutant

Publications (1)

Publication Number Publication Date
ATE279941T1 true ATE279941T1 (de) 2004-11-15

Family

ID=22456956

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99943674T ATE279941T1 (de) 1998-08-12 1999-08-11 Nicht-virulente porphyromonas gingivalis mutante

Country Status (7)

Country Link
US (4) US6254863B1 (de)
EP (1) EP1105156B1 (de)
AT (1) ATE279941T1 (de)
AU (1) AU761114B2 (de)
CA (1) CA2340070C (de)
DE (1) DE69921330T2 (de)
WO (1) WO2000009156A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254863B1 (en) * 1998-08-12 2001-07-03 Loma Linda University Non-virulent Porphyromonas gingivalis mutant
AU2003294350A1 (en) * 2002-11-18 2004-06-15 Boston Medical Center Corporation Immunization with porphyromonas gingivalis protects against heart disease
MXPA05008342A (es) 2003-02-06 2006-02-28 Cerus Corp Listeria atenuada para la entrada a las celulas no fagociticas, vacunas que comprenden la listeria, y metodos de uso de las mismas.
CA2515298C (en) 2003-02-06 2014-04-08 Cerus Corporation Modified free-living microbes, vaccine compositions and methods of use thereof
US7695725B2 (en) 2003-02-06 2010-04-13 Aduro Biotech Modified free-living microbes, vaccine compositions and methods of use thereof
CN1758923B (zh) * 2003-02-06 2013-04-24 阿杜罗生物科技公司 进入非吞噬细胞被衰减的利斯特氏菌、含有该利斯特氏菌的疫苗
US7842289B2 (en) 2003-12-24 2010-11-30 Aduro Biotech Recombinant nucleic acid molecules, expression cassettes, and bacteria, and methods of use thereof
US20060208737A1 (en) * 2005-03-16 2006-09-21 Baker Hughes Incorporated Calibration of xx, yy and zz induction tool measurements
US10925951B2 (en) * 2015-12-15 2021-02-23 Institut National De La Sante Et De La Recherche Medicale (Inserm) Vaccination against diabetes, obesity and complications thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6254863B1 (en) * 1998-08-12 2001-07-03 Loma Linda University Non-virulent Porphyromonas gingivalis mutant

Also Published As

Publication number Publication date
EP1105156A1 (de) 2001-06-13
CA2340070A1 (en) 2000-02-24
AU761114B2 (en) 2003-05-29
EP1105156A4 (de) 2002-07-10
US20040137568A1 (en) 2004-07-15
WO2000009156A1 (en) 2000-02-24
CA2340070C (en) 2003-11-11
US6585977B1 (en) 2003-07-01
US6586227B2 (en) 2003-07-01
DE69921330T2 (de) 2006-03-09
US20010012512A1 (en) 2001-08-09
DE69921330D1 (de) 2004-11-25
WO2000009156A9 (en) 2001-03-22
US6254863B1 (en) 2001-07-03
AU5672499A (en) 2000-03-06
EP1105156B1 (de) 2004-10-20

Similar Documents

Publication Publication Date Title
BG103740A (en) Phytostyrene composition for the prevention of the alzheimer's disease
AU2610799A (en) Glp-1 derivatives with helix-content exceeding 25 per cent, forming partially structured micellar-like aggregates
LU90987I2 (fr) Copaxone et ses dérivés pharmaceutiquement acceptables
BG102668A (en) Application of ppar-alpha and prar-gamma antagonist for the treatment of syndrome x
BR9710689A (pt) Processo para tratar diarr-ia aguda e para proporcionar terapia a um mam¡fero tendo diarr-ia e prepara-Æo terap-utica para redu-Æo de sintomas de diarr-ia
PL336580A1 (en) Fine-molecular compounds useful in treating inflammatory diseases
CA2289717A1 (en) Novel therapy for constipation
EP0954976A3 (de) Harter Kandiszucker mit verhältnismässig hohem Feuchtigkeitsgehalt und hoher Härte, und Herstellungsverfahren
ATE279941T1 (de) Nicht-virulente porphyromonas gingivalis mutante
PL323617A1 (en) Pharmaceutical preparation for treating oestrogen-dependent carcinomas
BR9609041A (pt) "terapia de substituição para cáries dentais".
EP1086689A3 (de) Pharmazeutische Zubereitungen Cefaclor enthaltend
BG101232A (en) Bactericides
DK0795604T3 (da) Bakteriestammer med ændret galdesyremetabolisme og deres anvendelse
BG104999A (en) Cyclopentanone dihydropyridine compositions useful as potassium channel openers
NO934293L (no) Fremgangsmåte og streptomycesstamme for fremstilling av antiparastiske forbindelser
GB9526331D0 (en) Novel method
MX9503625A (es) Metodo para reducir el daño por radicales libres en celulas de mamiferos vivos.
TW374764B (en) Antitumor and antileukaemic compounds, their preparation and pharmaceutical composition containing them
UA37488A (uk) Спосіб лікування хронічного кон'юнктивіту
UA30798A (uk) Спосіб пролонгованої терапії онкологічних хворих
NO20062246L (no) Oralt immunstimulerende materiale omfattende (1-4)- bundet beta-D-mannuronsyre, samt fremgangsmate for a stimulere immunsystemet av pattedyr, fugler og krypdyr med et preparat som inneholder materialet
MX9701532A (es) Procedimiento para aumentar los niveles de testosterona.
PL292753A1 (en) Method of obtaining novel (+)-1-methyl-trans-2(2-(n,n-diethylamine)ethoxy)-trans-4-((1-hydroxy-1-methyl)ethyl) bicyclo (3.1.0) hexane

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties